KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Share-based Compensation (2016 - 2025)

Amgen (AMGN) has 13 years of Share-based Compensation data on record, last reported at $125.0 million in Q4 2025.

  • For Q4 2025, Share-based Compensation fell 6.72% year-over-year to $125.0 million; the TTM value through Dec 2025 reached $494.0 million, down 6.79%, while the annual FY2025 figure was $494.0 million, 6.79% down from the prior year.
  • Share-based Compensation reached $125.0 million in Q4 2025 per AMGN's latest filing, down from $127.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $161.0 million in Q4 2023 and bottomed at $47.0 million in Q1 2023.
  • Average Share-based Compensation over 3 years is $121.2 million, with a median of $126.0 million recorded in 2025.
  • Peak YoY movement for Share-based Compensation: soared 119.15% in 2024, then decreased 17.48% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $161.0 million in 2023, then fell by 16.77% to $134.0 million in 2024, then dropped by 6.72% to $125.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $125.0 million in Q4 2025, $127.0 million in Q3 2025, and $157.0 million in Q2 2025.